NEW YORK, Feb. 21, 2014 /PRNewswire/ -- Harwood Feffer LLP ( www.hfesq.com) is investigating potential claims against the board of directors of Emeritus Corp. ("Emeritus" or the "Company") (NYSE: ESC) concerning the proposed acquisition of the Company by Brookdale Senior Living Inc. ("Brookdale").
Under the terms of the proposed transaction, Emeritus shareholders would receive 0.95 shares of Brookdale per Emeritus share held.
On February 20, 2014, it was reported in the media that National Interstate's independent directors do not support the transaction and have not had sufficient opportunity to review its terms.
Our investigation concerns whether the Emeritus board of directors is fulfilling its fiduciary duties, maximizing the value of the Company, disclosing all material benefits and costs, and obtaining full and fair consideration for Company shareholders.If you own Emeritus shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact: Benjamin I. Sachs-Michaels, Esq. Daniella Quitt, Esq. Robert I. Harwood, Esq.Harwood Feffer LLP488 Madison Avenue New York, New York 10022Phone Numbers: (877) 935-7400(212)935-7400Email: email@example.com Website: http://www.hfesq.com Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website ( http://www.hfesq.com) for more information about the firm. Attorney Advertising © 2014 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP ( www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. Photo: http://photos.prnewswire.com/prnh/20120215/MM54604LOGO SOURCE Harwood Feffer LLP
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts